Clinical and genetic study of Japanese patients with type 3 Gaucher disease
- 31 August 2009
- journal article
- Published by Elsevier BV in Molecular Genetics and Metabolism
- Vol. 97 (4), 272-277
- https://doi.org/10.1016/j.ymgme.2009.05.001
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Randomized, controlled trial of miglustat in Gaucher's disease type 3Annals of Neurology, 2008
- Outcome of type III Gaucher disease on enzyme replacement therapy: Review of 55 casesJournal of Inherited Metabolic Disease, 2007
- Neurologic Improvement in a Type 3 Gaucher Disease Patient Treated with Imiglucerase/Miglustat CombinationEpilepsia, 2007
- Ten years’ experience of enzyme infusion therapy of Norrbottnian (type 3) Gaucher diseaseActa Paediatrica, 2006
- Divergent phenotypes in Gaucher disease implicate the role of modifiersJournal of Medical Genetics, 2005
- Convection perfusion of glucocerebrosidase for neuronopathic Gaucher's diseaseAnnals of Neurology, 2005
- N-Octyl-β-valienamine up-regulates activity of F213I mutant β-glucosidase in cultured cells: a potential chemical chaperone therapy for Gaucher diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2004
- Type 1 Gaucher Disease: Phenotypic Expression and Natural History in Japanese PatientsBlood Cells, Molecules, and Diseases, 1998
- TEN YEARS' EXPERIENCE OF BONE MARROW TRANSPLANTATION FOR GAUCHER DISEASETransplantation, 1995
- A Mutation in the Human Glucocerebrosidase Gene in Neuronopathic Gaucher's DiseaseThe New England Journal of Medicine, 1987